|
ERF expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.36719999555402E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.80300030250669E-10 |
| Normal-vs-Stage2 |
5.400100E-03 |
| Normal-vs-Stage3 |
2.702300E-03 |
| Normal-vs-Stage4 |
4.858000E-02 |
| Stage1-vs-Stage2 |
3.408800E-01 |
| Stage1-vs-Stage3 |
3.580300E-03 |
| Stage1-vs-Stage4 |
2.19320000000023E-05 |
| Stage2-vs-Stage3 |
3.758200E-01 |
| Stage2-vs-Stage4 |
1.062440E-01 |
| Stage3-vs-Stage4 |
2.593800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.62680000043758E-07 |
| Normal-vs-AfricanAmerican |
1.019150E-04 |
| Normal-vs-Asian |
3.406100E-02 |
| Caucasian-vs-AfricanAmerican |
3.101700E-02 |
| Caucasian-vs-Asian |
8.056400E-01 |
| AfricanAmerican-vs-Asian |
4.979000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.83940000000927E-05 |
| Normal-vs-Female |
9.7638996887639E-10 |
| Male-vs-Female |
5.029800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.033020E-01 |
| Normal-vs-Age(41-60Yrs) |
3.81799999948917E-07 |
| Normal-vs-Age(61-80Yrs) |
2.10079999996005E-06 |
| Normal-vs-Age(81-100Yrs) |
2.182000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.962000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.569800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.727400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.460000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.996400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.540400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.354300E-04 |
| Normal-vs-Grade 2 |
6.22459994659152E-09 |
| Normal-vs-Grade 3 |
1.555750E-04 |
| Normal-vs-Grade 4 |
1.192590E-01 |
| Grade 1-vs-Grade 2 |
2.769700E-04 |
| Grade 1-vs-Grade 3 |
4.42020000046561E-07 |
| Grade 1-vs-Grade 4 |
6.826300E-04 |
| Grade 2-vs-Grade 3 |
1.845570E-02 |
| Grade 2-vs-Grade 4 |
3.024900E-04 |
| Grade 3-vs-Grade 4 |
1.026980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.08529851772232E-11 |
| Normal-vs-ccB subtype |
2.076400E-01 |
| ccA subtype-vs-ccB subtype |
2.30169994175355E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.579570E-04 |
| Normal-vs-N1 |
1.811390E-01 |
| N0-vs-N1 |
1.985500E-04 |
|
|
